Risky regulations: Is the FDA's clunky process impeding progress?

May 23, 2011 by MassDevice staff

U.S. Rep. Erik Paulsen (R-Minn.) announced plans to push legislation to modernize and streamline FDA processes at the MedTech Investing Conference in Minneapolis last week.

High on Paulsen's priorities are the development of an "Innovation Pathway" for pioneering medical devices and blocking a proposed $20 billion tax on the medical device industry.

Permalink